Chapter 13 Modified Nucleosides and Nucleobases in Urine and Serum as Selective Markers for The Whole-Body Turnover of tRNA, rRNA and mRNA-CAP - Future Prospects and Impact

Journal of Chromatography Library

Volumn 45, Issue , 1990, Pages C389-C441

  Schöch, Gerhard ^a   Sander, Gernot ^a   Topp, Heinrich ^a   Heller Schoch, Gesa ^a  

^a Forschungsinstitut fü Kinderernährung ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957013355     PISSN: 03014770     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0301-4770(08)61551-1     Document Type: Article

References (128)

1. Weissmann, B., Bromberg, P.A., Gutman, A.B., The purine bases of human urine II. Semi quantitative estimation and isotope incorporation. J. Bioi. Chem. 224 (1957), 423–434
2. Weissmann, B., Gutman, A.B., The identification of 6-succinoaminopurine and of 8-hydroxy-7-methylguanine as normal human urinary constituents. J. Biol. Chem. 229 (1957), 239–250
3. Weissman, S., Eisen, A.Z., Lewis, M., Karon, M., Pseudo-uridine metabolism III. Studies with isotopically labeled pseudouridine. J. Lab. Clin. Med. 60 (1962), 40–47
4. Mandel, L.R., Srinivasan, P.R., Borek, E., Origin of urinary methylated purines. Nature 209 (1966), 586–588
5. Dugaiczyk, A., Eiler, J.J., Lack of catabolism of 5-ribo-syluracil in man. Nature 212 (1966), 611–612
6. Craddock, V.M., Mattocks, A.R., Magee, P.N., The fate of 7[14C]-methylguanine after administration to the rat, Bio-chem. J. 109 (1968), 75–78
7. Chheda, G.B., Mittelman, A., Grace, J.T. Jr., Nucleosides in human urine: isolation and identification of N2-dimeth-ylguanosine, 1-methylinosine, and N2-methylguanosine from normal human urine. J. Pharm. Sci. 58 (1969), 75–78
8. Hong, C.I., Chheda, G.B., Murphy, G.P., Mittelman, A., Metabolism of N-(purin-6-ylcarbamoyl)-L-threonine riboside in rat and man. Biochem. Pharmacol. 22 (1973), 1927–1936
9. Chang, S.Y., Lakings, D.B., Zumwalt, R.W., Gehrke, C.W., Waalkes, T.P., Quantitative determination of methylated nucleosides and pseudouridine in urine by gas-liquid chromatog-raphy. J. Lab. Clin. Med. 83 (1974), 816–830
10. Chheda, G.B., Purine, pyrimidine, pyridine, and imidazole derivatives excreted in human urine. Fasman, G.D., (eds.) Handbook of Biochemistry and Molecular Biology 3rd ed, Nucleic Acids Vol. 1, 1975, CRC Press, Cleveland, 251–270
11. Schöch, G., Leifer, W., Grüttner, R., Ausscheidung von Nucleinsäureabbauprodukten im Urin: Meβsmethodik und Bedeu-tung. Monatsschr. Kinderheilkd. 124 (1976), 428–429
12. Oziel, M., Smith, L.H., Taylor, S.A., Modified nucleosides in urine: selective removal and analysis. Clin. Chem. 22 (1976), 1451–1455
13. Davis, G.E., Suits, R.D., Kuo, K.C., Gehrke, C.W., Waalkes, T.P., Borek, E., High-performance liquid chromatogrphic separation and quantitation of nucleosides in urine and some other biological fluids. Clin. Chem. 23 (1977), 1427–1435
14. Gehrke, C.W., Kuo, K.C., Davis, G.E., Suits, R.D., Waalkes, T.P., Borek, E., Quantitative high-performance liquid chromato-graphy of nucleosides in biological materials. J. Chroma-togr. 150 (1978), 455–476
15. Gehrke, C.W., Kuo, K.C., Waalkes, T.P., Borek, E., Patterns of urinary excretion of modified nucleosides. Cancer Res. 39 (1979), 1150–1153
16. Gehrke, C.W., Kuo, K.C., Major and modified nucleosides, RNA, and DNA. Kabra, P.M., Marton, L.J., (eds.) Liquid Chromatography in Clinical Analysis, 1980, The Humana Press, Clifton, NJ, 409–443
17. Schöch, G., Thomale, J., Lorenz, H., Suberg, H., Karsten, U., A new method for the simultaneous analysis of unmodified and modified urinary nucleosides and nucleobases by high-performance liquid chromatography. Clin. Chim. Acta 108 (1980), 247–257
18. Gehrke, C.W., Kuo, K.C., Zumwalt, R.W., Chromatography of nucleosides. J. Chromatogr. 188 (1980), 129–147
19. Zakaria, M., Brown, P.R., High-performance liquid column chromatography of nucleotides, nucleosides and bases. J. Chromatogr. 226 (1981), 267–290
20. Void, B.S., Keith, D.E. Jr., Slavik, M., Urine levels of N-[9-(β-D-ri bofuranosyl)puri n-6-yl carbamoyll-L-threoni ne,N6-(2-isopentenyl) adenosine, and 2′-0-metnylguanosine as determined by radioimmunoassay for normal subjects and cancer patients. Cancer Res. 42 (1982), 5265–5269
21. Chung, T.G., Kanazawa, I., Saito, A., Determination of 2,8-dihydroxyadenine in urine by high-performance anion-exchange liquid chromatography. J. Chromatogr. 277 (1983), 300–304
22. Kaneko, K., Fujimori, S., Kamatam, N., Akaoka, I., Methyl-thioadenosine in urine from normal subjects and cancer patients. Biochim. Biophys. Acta 802 (1984), 169–174
23. Topp, H., Sander, G., Schöch, G., A high-performance liquid chromatographic method for the determination of pseudouridine and uric acid in native human urine and ultrafiltrated serum. Anal. Biochem. 150 (1985), 353–358
24. Sander, G., Wieland, J., Topp, H., Heller-Schöch, G., Erb, N., Schöch, G., An improved method for the simultaneous analysis of normal and modified urinary nucleosides and nucleobases by high-performance liquid chromatography. Clin. Chim. Acta 152 (1985), 355–361
25. Gehrke, C.W., Kuo, K.C., High resolution quantitative high-performance liquid chromatography-UV-spectrometry analysis of nucleosides in tRNA, mRNA, DNA, and physiological fluids. Bull. Mol. Biol. Med. 10 (1985), 119–142
26. Dutta, S.P., Grossberg, A., Bhargava, A.K., Chheda, G.B., Radioimmunoassay for a novel urinary nucleoside, N6-suc-cinyladenosine. Anticancer Res. 6 (1986), 135–138
27. Apell, G., Buschmann, F.L., Sharma, O.K., Improved and rapid method for quantisation of modified nucleosides in urine and sera with Radial-Pak cartridge. J. Chromatogr. 374 (1986), 149–154
28. Adams, W.S., Davis, F., Nakatani, M., Purine and pyrimidine excretion in normal and leukemic subjects. Am. J. Med. 28 (1960), 726–734
29. Park, R.W., Holland, J.F., Jenkins, A., Urinary purines in leukemia. Cancer Res. 22 (1962), 469–477
30. Borek, E., Kerr, S., Atypical transfer RNAs and their origin in neoplastic cells. Adv. Cancer Res., 15, 1972
31. Waalkes, T.P., Dinsmore, S.R., Mrochek, J.E., Urinary excretion by cancer patients of the nucleosides N2,N2-dimethyl-guanosine, 1-methylinosine, and pseudouridine. J. Natl. Cancer Inst. 51 (1973), 271–274
32. Mrochek, J.E., Dinsmore, S.R., Waalkes, T.P., Analytic techniques in the separation and identification of specific purine and pyrimidine degradation products of tRNA: application to urine samples from cancer patients. J. Natl. Cancer Inst. 53 (1974), 1553–1563
33. Waalkes, T.P., Borek, E., The biochemical assessment of the malignant status in man: aspects related to tRNA modification, 1975, Excerpta Medica, Amsterdam 15–31 in: Excerpta Medica Int. Congr. Series No. 375
34. Waalkes, T.P., Gehrke, C.W., Zumwalt, R.W., Chang, S.Y., Lakings, D.B., Tormey, D.C., Ahmann, D.L., Moertel, C.G., The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer. Cancer 36 (1975), 390–398
35. Tormey, D.C., Waalkes, T.P., Ahmann, D., Gehrke, C.W., Zumwalt, R.W., Snyder, J., Hansen, H., Biological markers in breast carcinoma I. Incidence of abnormalities of CEA, HCG, three polyamines, and three minor nucleosides. Cancer 35 (1975), 1095–1100
36. Schöch, G., Heller-Schöch, G., Molekularbiologie und klinische Bedeutung des Stoffwechsels normaler und modi-fizierter Nucleobasen. Helv. Paediatr. Acta, Suppl. 38 (1977), 7–171
37. Lakings, D.B., Waalkes, T.P., Borek, E., Gehrke, C.W., Mrochek, J.E., Longmore, J., Adamson, R.H., Composition, associated tissue methyltransferase activity, and catabolic end products of transfer RNA from carcinogen-induced hepatoma and normal monkey livers. Cancer Res. 37 (1977), 285–292
38. Borek, E., Baliga, B.S., Gehrke, C.W., Kuo, K.C., Belman, S., Troll, W., Waalkes, T.P., High turnover rate of transfer RNA in tumor tissue. Cancer Res. 37 (1977), 3362–3366
39. Speer, J., Gehrke, C.W., Kuo, K.C., Waalkes, T.P., Borek, E., TRNA breakdown products as markers for cancer. Cancer 44 (1979), 2120–2123
40. Schöch, G., Winkler, K., Heller-Schöch, G., Baisch, H., Die Analyse von normalen und methylierten Nucleobasen im Urin als neues Kriterium für Diagnose und Verlauf von Malignomen. Klin. Pädiatr. 191 (1979), 197–204
41. Schöch, G., Garbrecht, M., Heller-Schöch, G., Baisch, H., Leifer, W., Die Ausscheidung von normalen und modifizierten Nucleobasen im Urin bei chronischen myeloproliferativen Syndromen. Blut 38 (1979), 391–396
42. Tormey, D.C., Waalkes, T.P., Gehrke, C.W., Biological markers in breast carcinoma - clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosine. J. Surg. Oncol. 14 (1980), 267–273
43. Waalkes, T.P., Abeloff, M.D., Ettinger, D.S., Woo, K.B., Gehrke, C.W., Kuo, K.C., Borek, E., Modified ribonucleosides as biological markers for patients with small cell carcinoma of the lung. Eur. J. Cancer Clin. Oncol. 18 (1982), 1267–1274
44. Waalkes, T.P., Rosenshein, N.B., Shaper, J.H., Ettinger, D.S., Woo, K.B., Paone, J.F., Gehrke, C.W., A feasability study in the development of biological markers for ovarian cancer. J. Surg. Oncol. 21 (1982), 207–214
45. Waalkes, T.P., Abeloff, M.D., Ettinger, D.S., Woo, K.B., Gehrke, C.W., Kuo, K.C., Borek, E., Biological markers and small cell carcinoma of the lung. Cancer 50 (1982), 2457–2464
46. Trewyn, R.W., Glaser, R., Kelly, D.R., Jackson, D.G., Graham, W.P. III, Speicher, C.E., Elevated nucleoside excretion by patients with nasopharyngeal carcinoma. Preliminary diagnostic/prognostic evaluations, Cancer 49 (1982), 2513–2517
47. Thomale, J., Nass, G., Elevated urinary excretion of RNA catabolites as an early signal of tumor development in mice. Cancer Lett 15 (1982), 149–159
48. Higley, B., DeMello, J. Jr., Oakes, D.J., Giles, G.R., Urinary pseudouridine/creatinine ratio as an indicator of gastrointestinal cancer. Brit. J. Surg. 69 (1982), 699–701
49. Sharma, O.K., Waalkes, T.P., Gehrke, C.W., Borek, E., Applications of urinary nucleosides in cancer diagnosis and cancer management. Cancer Detect. Prev. 6 (1983), 77–85
50. Salvatore, F., Colonna, A., Costanzo, F., Russo, T., Esposito, F., Cimino, F., Modified nucleosides in body fluids of tumor-bearing patients. Recent Results Cancer Res. 84 (1983), 360–377
51. Rasmuson, T., Björk, G.R., Pseudouridine: a modified nucleoside as biological marker in malignant lymphomas. Cancer Detect. Prev. 6 (1983), 293–296
52. Müller, J., Erb, N., Heller-Schöch, G., Lorenz, H., Winkler, K., Schöch, G., Multivariate analysis of urinary RNA catabolites in malignancies: cross-sectional and longitudinal studies. Recent Results Cancer Res. 84 (1983), 317–330
53. Heldman, D.A., Grever, M.R., Miser, J.S., Trewyn, R.W., Relationship of urinary excretion of modified nucleosides to disease status in cnildhood acute lymphoblastic leukemia. J. Natl. Cancer Inst. 71 (1983), 269–273
54. Heldman, D.A., Grever, M.R., Trewyn, R.W., Differential excretion of modified nucleosides in adult acute leukemia. Blood 61 (1983), 291–296
55. Heldman, D.A., Grever, M.R., Speicher, C.E., Trewyn, R.W., Urinary excretion of modified nucleosides in chronic myelo-genous leukemia. J. Lab. Clin. Med. 101 (1983), 783–792
56. Fischbein, A., Sharma, O.K., Selikoff, I.J., Borek, E., Urinary excretion of modified nucleosides in patients with malignant mesothelioma. Cancer Res. 43 (1983), 2971–2974
57. Borek, E., Sharma, O.K., Brewer, J.I., Urinary nucleic acid breakdown products as markers for trophoblastic diseases. Am. J. Obstet. Gynecol. 146 (1983), 906–910
58. Borek, E., Sharma, O.K., Waalkes, T.P., New applications of urinary nucleoside markers. Recent Results Cancer Res. 84 (1983), 301–316
59. Borek, E., Waalkes, T.P., Gehrke, C.W., Tumor markers derived from nucleic acid components, Cancer Detect. Prev. 6 (1983), 67–71
60. Thomale, J., Luz, A., Nass, G., Increased urinary levels of RNA catabolites in mice as early indicators for malignant growth, Cancer Detect. Prev. 6 (1983), 73–76
61. Rasmuson, T., Bqörk, G.R., Damber, L., Holm, S.E., Jacobsson, L., Jeppsson, A., Stigbrand, T., Westman, G., Tumour markers in colorectal carcinoma An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine. Acta Radiol. Oncol. 23 (1984), 27–32
62. Lin, W., Mackenzie, J.W., Clark, I., Excretion of RNA catabolites by rats with hepatoma transplants. Cancer Letters 22 (1984), 187–192
63. Borek, E., Toward a universal tumour marker. Tumour Biology 5 (1984), 1–14
64. Rasmuson, T., Björk, G.R., Excretion of pseudouridine in urine as a tumor marker in malignant diseases. Bull. Mol. Biol. Med. 10 (1985), 143–154
65. Nass, G., Thomale, J., Luz, A., Friedrich, U., Excretion of modified nucleosides by malignant cells in vivo and in vitro and its clinical relevance. Bull. Mol. Biol. Med. 10 (1985), 155–168
66. Nakano, K., Shindo, K., Yasaka, T., Yamamoto, H., Reversed-phase liquid chromatographic investigation of nucleosides and bases in mucosa and modified nucleosides in urines from patients with gastrointestinal cancer. J. Chromatogr. 332 (1985), 127–137
67. Nakano, K., Shindo, K., Yasaka, T., Yamamoto, H., Reversed-phase high-performance chromatographic investigation of muc-osal nucleosides and bases and urinary modified nucleosides of gastrointestinal cancer patients. J. Chromatogr. 343 (1985), 21–33
68. Chheda, G.B., Dutta, S.P., Mittelman, A., Montgomery, J.A., Sethi, S.K., McCloskey, J.A., Patrzyc, H.B., Isolation and characterization of a novel nucleoside, 7–0-D-ribofuranosyl-hypoxanthine, from the urine of a chronic myelogenous leukemia patient. Cancer Res. 45 (1985), 5958–5963
69. Buhl, L., Dragsholt, C., Svendsen, P., Hage, E., Buhl, M.R., Urinary hypoxanthine and pseudouridine as indicators of tumor development in mesothelioma-transplanted nude mice. Cancer Res. 45 (1985), 1159–1162
70. Borek, E., The morass of tumor markers. Trends Biochem. Sci. 10 (1985), 182–184
71. Void, B.S., Kraus, L.E., Rimer, V.G., Coombes, R.C., Use of a monoclonal antibody to detect elevated levels of a modified nucleosi de, N-[9-(β-D-ri bofuranosyl)puri n-6-ylcarbamoyl]-L-threonine, in the urine of breast cancer patients. Cancer Res. 46 (1986), 3164–3167
72. Tamura, S., Fujii, J., Nakano, T., Hada, T., Higashino, K., Urinary pseudoundine as a tumor marker in patients with small cell lung cancer. Clin. Chim. Acta 154 (1986), 125–132
73. Clemens, P., Schöch, G., Ziemer, G., Altenhoff, J., Erb, N., Lorenz, H., Müller, J., Gruttner, R., Ausscheidung von methyl-ierten Nukleosiden in der initialen Therapiephase bei einem Fall von Anorexia nervosa, Pädiatr. Pädol. 17 (1982), 157–163
74. Clemens, P., Ziemer, G., Altenhoff, J., Grüttner, R., Heller-Schöch, G., Schöch, G., Urinary excretion of methylated nucleosides in different states of failure to thrive. De Bruyn, C.H.M.M., Simmonds, H.A., Muller, M.M., (eds.) Purine metabolism in man, 1984, Plenum Publishing Corp, New York, London, 297–300 IV, part A
75. Mills, G., Schmalstieg, F.C., Goldblum, R.M., Urinary excretion of modified purines and nucleosides in immuno-deficient children. Biochem. Med. 34 (1985), 37–51
76. Borek, E., Sharma, O.K., Buschman, F.L., Cohn, D.L., Penley, K.A., Judson, F.N., Dobozin, B.S., Horsburgh, C.R. Jr., Kirkpatrick, C.H., Altered excretion of modified nucleosides and β-aminoisobutyric acid in subjects with acquired immunodeficiency syndrome or at risk for acquired immunodeficiency syndrome. Cancer Res. 46 (1986), 2557–2561
77. Schöch, G., Heller-Schöch, G., Lorenz, H., Baisch, H., Weser, M., Leifer, W., Gruttner, R., Die Ausscheidung von Nuclein-säureabbauprodukten in Abhängigkeit von Lebensalter und Wachstum. Monatsschr. Kinderheilkd. 125 (1977), 542–543
78. Schöch, G., Lorenz, H., Heller-Schöch, G., Baisch, H., Clemens, P., Die Altersabhängigkeit der normal en und modi-fizierten Nucleobasen im Urin als Ausdruck der Wachstums-geschwindigkeit. Monatsschr. Kinderheilkd. 129 (1981), 29–33
79. Müller-Wickop, J., Lorenz, H., Winkler, K., Erb, N., The age dependency of the creatinine-related concentration of ribo-nucleosides in human urine. J. Clin. Chem. Clin. Biochem. 24 (1986), 993–999
80. Schöch, G., Heller-Schöch, G., Müller, J., Heddrich, M., Grüttner, R., Determination of RNA metabolism as indicator of nutritional status. Klin. Pädiatr. 194 (1982), 317–319
81. Schöch, G., Heller-Schöch, G., Müller, J., Clemens, P., Holtgrewe, A., Heddrich, M., Die Ausscheidung normaler und modifizierter RNA-Kataboliten sowie von Kreatinin im Urin in Abhängigkeit von der Ernährung bei Kindern. Monatsschr. Kinderheilkd. 131 (1983), 259–263
82. Sander, G., Topp, H., Wieland, J., Heller-Schöch, G., Schöch, G., Possible use of urinary modified RNA metabolites in the measurement of RNA turnover in the human body. Hum. Nutr. Clin. Nutr. 40C (1986), 103–118
83. Sander, G., Hülsemann, J., Topp, H., Heller-Schöch, G., Schöch, G., Protein and RNA turnover in preterm infants and adults: a comparison based on urinary excretion of 3-methyl-histidine and of modified one-way RNA catabolites. Ann. Nutr. Metab. 30 (1986), 137–142
84. Sander, G., Topp, H., Heller-Schöch, G., Wieland, J., SchSch, G., Ribonucleic acid turnover in man: RNA catabolites in urine as measure for the metabolism of each of the three major species of RNA. Clin. Sci. 71 (1986), 367–374
85. Topp, H., Sander, G., Heller-Schöch, G., Schöch, G., Determination of 7-metnylguanine, N2,N2-dimethylguanosine and pseudouridine in ultrafiltrated serum of healthy adults by high-performance liquid chromatography. Anal. Biochem. 161 (1987), 49–56
86. Hagemeier, E., Kemper, K., Boos, K.S., Schlimme, E., On-line high performance liquid chromatography analysis of monomeric ribonucleoside compounds in biological fluids. J. Chroma-togr. 282 (1983), 663–669
87. Hagemeier, E., Kemper, K., Boos, K.S., Schlimme, E., Development of a chromatographic method for the quantitative determination of minor ribonucleosides in physiological fluids. J. Clin. Chem. Clin. Biochem. 22 (1984), 175–184
88. Ikemura, T., Correlation between the abundance of yeast transfer RNAs and the occurrence of the respective codons in protein genes. J. Mol. Biol. 158 (1982), 573–597
89. Chevallier, A., Garel, J.P., Differential synthesis rates of tRNA species in the silk gland of Bombyx mori are required to promote tRNA adaptation to silk messages. Eur. J. Biochem. 124 (1982), 477–482
90. Grosjean, H., Fiers, W., Preferential codon usage in pro-karyotic genes: the optimal codon-anticodon interaction energy and the selective codon usage in efficiently expressed genes. Gene 18 (1982), 199–209
91. Ikemura, T., Codon usage and tRNA content in unicellular and multicellular organisms. Mol. Biol. Evolut. 2 (1985), 13–34
92. Sprinzl, M., Moll, J., Meissner, F., Hartmann, T., Compilation of tRNA sequences. Nucl. Acids Res. 13 (1985), r1–r49
93. G. Sander, H. Topp, G. Heller-Schöch and G. Schöch The modified nucleosides in tRNA: selection of markers in urine for estimating whole-body tRNA turnover in rats and man, in preparation
94. Khan, M.S.N., Salim, M., Maden, B.E.H., Extensive homologies between the methylated nucleotide sequences in several vertebrate ribosomal ribonucleic acids. Biochem. J. 169 (1978), 531–542
95. Hughes, D.G., Maden, B.E.H., The pseudouridine contents of the ribosomal ribonucleic acids of three vertebrate species. Biochem. J. 171 (1978), 781–786
96. Björk, G.R., Modified nucleosides in RNA - their formation and function. Apirion, D.A., (eds.) Processing of RNA, 1984, CRC Press, Boca Raton, Florida, 292–330
97. Thomas, G., Gordon, J., Rogg, H., N4-acetylcytidine A previously unidentified labile component of the small subunit of eukaryotic ribosomes. J. Biol. Chem. 253 (1978), 1101–1105
98. Chan, Y.L., Olvera, J., Wool, I.G., The structure of rat 28S ribosomal ribonucleic acid inferred from the sequence of nucleotides in a gene. Nucl. Acids Res. 11 (1983), 7819–7831
99. Chan, Y.L., Gutell, R., Noller, H.F., Wool, I.G., The nucleo-tide sequence of a rat 18S ribosomal ribonucleic acid gene and a proposal for the secondary structure of 18S ribosomal ribonucleic acid. J. Biol. Chem. 259 (1984), 224–230
100. Nazar, R.N., Sitz, T.O., Busch, H., Structural analyses of mammalian ribosomal ribonucleic acid and its precursors Nucleotide sequence of ribosomal 5.8S ribonucleic acid. J. Biol. Chem. 250 (1975), 8591–8597
101. Aoyama, K., Hidaka, S., Tanaka, T., Ishikawa, K., The nucleotide sequence of 5S RNA from rat liver ribosomes. J. Bio-chem. 91 (1982), 363–367
102. Rottman, F.M., Methylation of messenger RNA, Trends Biochem. Sci. 1 (1976), 217–219
103. Adams, J.M., Messenger RNA. Stewart, P.R., Letham, D.S., (eds.) The Ribonucleic Acids 2nd ed, 1977, Springer-Verlag, New York, 81–128
104. Busch, H., Reddy, R., Rothblum, L., Choi, Y.C., SnRNAs, SnRNPs, and RNA processing. Annu. Rev. Biochem. 51 (1982), 617–654
105. Stryer, L., Biochemistry 2nd ed, 1981, Freeman, San Francisco
106. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., Watson, J.D., Molecular Biology of the Cell, 1983, Garland Publishing Inc., New York and London
107. Waterlow, J.C., Garlick, P.J., Millward, D.J., Protein Turnover in Mammalian Tissues and in the Whole Body, 1978, North-Holland, Amsterdam
108. Gunning, P.W., Shooter, E.M., Austin, L., Jeffrey, P.L., Differential and coordinate regulation of the eukaryotic small molecular weight RNAs. J. Biol. Chem. 256 (1981), 6663–6669
109. Munro, H.N., Evolution of protein metabolism in mammals. Munro, H.N., (eds.) Mammalian Protein Metabolism, 3, 1969, Academic Press, New York, London, 133–182
110. Linder, M.C., Nutritional Biochemistry and Metabolism with Clinical Applications, 1984, Elsevier, New York
111. Brandhorst, B.P., McConkey, E.H., Stability of nuclear RNA in mammalian cells. J. Mol. Biol. 85 (1974), 451–463
112. Maden, B.E.H., Salim, M., The methylated nucleotide sequences in HeLa cell ribosomal RNA and its precursors. J. Mol. Biol. 88 (1974), 133–164
113. Lehmnger, A.L., Biochemistry, 1975, Worth Publishers, Inc., New York
114. Kjeldgaard, N.O., Gausing, K., Nomura, M., Tissieres, A., Lengyel, P., (eds.) Regulation of biosynthesis of ribosomes, 1974, Ribosomes, Cold Spring Harbor Laboratory, Cold Spring Harbor, 369–392
115. Lothrop, C.D. Jr., Uziel, M., Salvage of the modified nucleoside ribothymidine in cultured hamster embryo cells. Biochim. Biophys. Acta 698 (1982), 134–139
116. Chheda, G.B., Mittelman, A., N6-(2-isopentenyl)adenosine metabolism in man. Biochem. Pharmacol. 21 (1972), 27–37
117. H. Topp, unpublished observation
118. Katze, J.R., Gundiiz, U., Smith, D.L., Cheng, C.S., McCloskey, J.A., Evidence that the nucleic acid base queuine is incorporated intact into tRNA by animal cells. Biochemistry 23 (1984), 1171–1176
119. Forbes, G.B., Bruining, G.J., Urinary creatinine excretion and lean body mass. Am. J. Clin. Nutr. 29 (1976), 1359–1366
120. Kolar, K., Spitzhörnchen und Halbaffen. Grzimek, B., (eds.) Grzimeks Tierleben. Enzyklopädie des Tierreichs, 10, 1968, Kindler Verlag, Zürich, 243–258
121. H. Topp, E. Fuchs, G. Sander, G. Heller-Schöch G. Schöch (in preparation)
122. Reallexikon der Medizin und ihrer Grenzgebiete, 1. Auf1., Urban & Schwarzenberg, München Wien Baltimore, 1977
123. Hanoune, J., Agarwal, M.K., Studies on the half-life time of rat liver transfer RNA species. FEBS Lett. 11 (1970), 78–80
124. Warner, J.R., Nomura, M., Tissieres, A., Lengyel, P., (eds.) The assembly of ribosomes in eukaryotes, 1974, Ribosomes, Cold Spring Harbor Laboratory, Cold Spring Harbor, 461–488
125. Waterlow, J.C., Protein turnover with special reference to man. Q. J. Exp. Physiol. 69 (1984), 409–438
126. Bjornsson, T.D., Use of serum creatinine concentrations to determine renal function. Clin. Pharmacokin. 4 (1979), 200–222
127. Hall, R.H., Dunn, D.B., Natural occurrence of the modified nucleosides. Fasman, G.D., (eds.) Handbook of Biochemistry and Molecular Biology, 3rd Edition, 1, 1975, CRC Press, Cleveland, 216–251 Nucleic Acids
128. Young, V.R., Munro, H.N., NT-Methylhistidine (3-methyl-histidine) and muscle protein turnover: an overview. Fed. Proc 37 (1978), 2291–2300